Evaluation of liver fibrosis by transient elastography (Fibroscan®) in patients with inflammatory bowel disease treated with methotrexate: A multicentric trial

Scandinavian Journal of Gastroenterology

Volumn 47, Issue 5, 2012, Pages 575-579

  Barbero Villares, A ^a   Jiménez Ridruejo, J Mendoza ^a   Taxonera, C ^b   Lopez Sanroman A ^c   Pajares, R ^d   Bermejo, F ^e   Perez Calle J L ^c   Mendoza, J L ^b   Algaba, A ^e   Moreno Otero, R ^a   Mate J ^a   Gisbert, J P ^a  

^a Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c Gastroenterology Units of the Hospitals   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e HOSPITAL UNIVERSITARIO DE FUENLABRADA   (Spain)

Author keywords

fibroscan ; inflammatory bowel disease; liver fibrosis; methotrexate; transient elastography

Indexed keywords

AZATHIOPRINE; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; STEROID;

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CROHN DISEASE; DIGESTIVE TRACT PARAMETERS; DOSE RESPONSE; ELASTOGRAPHY; ENTERITIS; FEMALE; HUMAN; LIVER FIBROSIS; LIVER STIFFNESS; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE; SINGLE BLIND PROCEDURE; TRANSIENT ELASTOGRAPHY; TREATMENT DURATION; ULCERATIVE COLITIS;

ADULT; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; METHOTREXATE; MIDDLE AGED;

EID: 84859596466     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2011.647412     Document Type: Article

References (27)

1. Aithal GP, Haugk B, Das S, Card T, Burt AD, Record CO. Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified? Aliment Pharmacol Ther 2004;19:391-9. (Pubitemid 38297107)
2. Brion N, Paule B. Non-cancer uses of methotrexate. Presse Med 1996;25:1929-34.
3. Guidelines for monitoring drug therapy in rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Arthritis Rheum 1996;39:723-31.
4. Kremer JM, Alarcon GS, Lightfoot RW Jr, Willkens RF, Furst DE, Williams HJ, et al. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Arthritis Rheum 1994; 37:316-28. (Pubitemid 24093622)
5. Khokhar OS, Lewis JH. Hepatotoxicity of agents used in the management of inflammatory bowel disease. Dig Dis 28: 508-18.
6. Bonny C, Rayssiguier R, Ughetto S, Aublet-Cuvelier B, Baranger J, Blanchet G, et al. Medical practices and expectations of general practitioners in relation to hepatitis C virus infection in the Auvergne region. Gastroenterol Clin Biol 2003;27:1021-5. (Pubitemid 37516827)
7. Almasio PL, Niero M, Angioli D, Ascione A, Gullini S, Minoli G, et al. Experts' opinions on the role of liver biopsy in HCV infection: a Delphi survey by the Italian Association of Hospital Gastroenterologists (A.I.G.O.). J Hepatol 2005; 43:381-7. (Pubitemid 41111417)
8. Wong JB, Koff RS. Watchful waiting with periodic liver biopsy versus immediate empirical therapy for histologically mild chronic hepatitis C. A cost-effectiveness analysis. Ann Intern Med 2000;133:665-75.
9. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003;29:1705-13. (Pubitemid 38091720)
10. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128: 343-50. (Pubitemid 40439195)
11. Colletta C, Smirne C, Fabris C, Toniutto P, Rapetti R, Minisini R, et al. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology 2005;42:838-45. (Pubitemid 41401121)
12. de Ledinghen V, Douvin C, Kettaneh A, Ziol M, Roulot D, Marcellin P, et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr 2006;41:175-9.
13. Mendoza J, Gomez-Dominguez E, Moreno-Otero R. Transient elastography (Fibroscan), a new non-invasive method to evaluate hepatic fibrosis. Med Clin (Barc) 2006;126:220-2.
14. Moreno-Otero R, Trapero-Marugan M, Mendoza J. Liver fibrosis assessment by transient elastography in hepatitis C patients with normal alanine aminotransferase. Gut 2006;55: 1055-6. (Pubitemid 43962633)
15. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005;41:48-54. (Pubitemid 40066382)
16. Abenavoli L, Corpechot C, Poupon R. Elastography in hepatology. Can J Gastroenterol 2007;21:839-42. (Pubitemid 351255704)
17. Barbero-Villares A, Mendoza J, Trapero-Marugan M, Gonzalez-Alvaro I, Dauden E, Gisbert JP, et al. Evaluation of liver fibrosis by transient elastography in methotrexate treated patients. Med Clin (Barc) 2011.
18. Bruhl J, Schirren M, Wei C, Antoni C, Bocker U. Prospective noninvasive analysis of hepatic fibrosis in patients with Crohn's disease: correlation of transient elastography and laboratory-based markers. Eur J Gastroenterol Hepatol 23: 923-30.
19. Friedrich-Rust M, Hadji-Hosseini H, Kriener S, Herrmann E, Sircar I, Kau A, et al. Transient elastography with a new probe for obese patients for non-invasive staging of non-alcoholic steatohepatitis. Eur Radiol 20:2390-6.
20. Gomez-Dominguez E, Mendoza J, Rubio S, Moreno-Monteagudo JA, Garcia-Buey L, Moreno-Otero R. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. Aliment Pharmacol Ther 2006;24: 513-18. (Pubitemid 44051327)
21. Laharie D, Zerbib F, Adhoute X, Boue-Lahorgue X, Foucher J, Castera L, et al. Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn's disease patients treated with methotrexate. Aliment Pharmacol Ther 2006;23:1621-8. (Pubitemid 43727471)
22. Lupsor M, Badea R, Stefanescu H, GrigorescuM, Serban A, Radu C, et al. Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis. J Gastrointestin Liver Dis 19:53-60.
23. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996;24:289-93. (Pubitemid 26260021)
24. Carneiro SC, Cassia FF, Lamy F, Chagas VL, Ramos-e-Silva M. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages. J Eur Acad Dermatol Venereol 2008;22:25-9.
25. Ros S, Juanola X, Condom E, Canas C, Riera J, Guardiola J, et al. Light and electron microscopic analysis of liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy. Scand J Rheumatol 2002;31:330-6. (Pubitemid 35398741)
26. Berends MA, Snoek J, de Jong EM, Van Krieken JH, de Knegt RJ, van Oijen MG, et al. Biochemical and biophysical assessment of METHOTREXATE-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis. Liver Int 2007;27:639-45. (Pubitemid 47097314)
27. Thomas JA, Aithal GP. Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary? Am J Clin Dermatol 2005;6:357-63. (Pubitemid 43128288)